Brief: Basilea Pharmaceutica Primary ABB Books Are Oversubscribed - Bookrunner
Feb 23 (Reuters) - Bookrunner:
* BLOCK TRADE - BASILEA PHARMACEUTICA PRIMARY ABB: BOOKRUNNER SAYS BOOKS
ARE
OVERSUBSCRIBED
* BLOCK TRADE - BASILEA PHARMACEUTICA PRIMARY ABB: BOOKRUNNER SAYS INDICATED
DEMAND EXCEEDS DEAL SIZE
Further company coverage: BSLN.S
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Basilea Pharmaceutica AG, Allschwil
See all newsBrief: Basilea Pharmaceutica - Strong Cresemba Sales In Europe Trigger USD 37.5 Mln Milestone Payment
Basilea seen up after raising 2026 guidance
Brief: Basilea Expects 2026 Operating Profit Of CHF 115 Mln
Brief: Basilea Reports Presentation Of New Data For Fosmanogepix, Isavuconazole And Ceftobiprole At IDWeek 2026
RCS - Accession Theraptcs. - Accession Therapeutics: Board appointments